Company news
Argent Biopharma Ltd news in 2017
Argent Biopharma Ltd's news releases, calls and decks from 2017, newest first.
MXC Operational Update
December 17, 2017
New Year Launch of MGC Derma CBD Psoriasis Cream Confirmed
December 13, 2017
Binding Agreement to Supply $1m CBD Extract Annually
November 21, 2017
Definitive Supply Agreement Executed with HL Pharma
November 19, 2017
First Varm Cosmo Binding Purchase Order Received
November 14, 2017
MXC Enters Multi $M Australian Pharma Market
October 31, 2017
First $8m Binding Cosmetics Sales Agreement Signed
October 29, 2017
$40 Million White-Label CBD Cosmetics Agreement Executed
October 19, 2017
MXC Botanic Division Operational Update
October 12, 2017
Major EU Pharma Supply Agreement Signed with Lenis
October 2, 2017
Appendix 4E and Audited 2017 Financial Report
August 29, 2017
RMIT and MGC Pharmaceuticals Sign Strategic Agreement
August 23, 2017
Botanical Division Update - Europe and Australia
July 3, 2017
First European Distribution Deal Signed for API Products
June 19, 2017
EU Medical Cannabis License Granted with Strategic Agreement
June 5, 2017
Positive MGC Derma Clinical Test Results
May 22, 2017
CEO Appointment
May 10, 2017
Strategic Agreement Signed with RMIT
May 2, 2017
New EU Sales Agreements Signed For MGC Derma
May 1, 2017
Successful MXC First Cannabinoid Production
April 10, 2017
European API Extraction Facility Completed
April 5, 2017
Placement of $10m Closed Significantly Oversubscribed
March 16, 2017
Australian Legislation Changes Fast Track MXC
February 22, 2017
Cannabinoid Extraction Facility On Target Q2 Production
February 19, 2017
Medical Cannabis Clinical Study Commencing
February 13, 2017
Panax Acquisition Completed
February 6, 2017
Commencement of Dermatological Clinical Trials
January 25, 2017
European CPNP Approval Granted for Derma Products
January 8, 2017